Skip to main content

Month: March 2023

Corning’s New EDGE™ Distribution System Accelerates Data Center Cabling Installation by up to 70%

The pre-engineered solution helps meet demand for information processing in the cloud – simplifying installation, lowering overall costs, and reducing carbon footprint CORNING, N.Y., March 03, 2023 (GLOBE NEWSWIRE) — Corning Incorporated (NYSE:GLW), a global leader in optical communications innovations, today unveiled its newest connectivity solution, the EDGE™ Distribution System. Designed to meet the ever-growing demand for information processing in the cloud, this pre-engineered data center solution shortens installation time for server cabling by up to 70%, helps address shortages in skilled labor, and provides up to a 55% reduction in carbon footprint by minimizing materials and packaging. Today’s data centers – the massive storage hubs that support today’s data-rich applications – must expand to process increasing...

Continue reading

O2Micro Announces Completion of Merger

GEORGE TOWN, Grand Cayman, March 03, 2023 (GLOBE NEWSWIRE) — O2Micro International Limited (NASDAQ Global Select Market: OIIM) (“O2Micro” or the “Company”), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, today announced the completion of the merger (the “Merger”) with Rim Peak Technology Limited (“Merger Sub”), a wholly owned subsidiary of FNOF Precious Honour Limited (“Parent”), pursuant to the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as of September 30, 2022, among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company. Pursuant to the Merger Agreement, which was approved by the Company’s shareholders at an extraordinary...

Continue reading

Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

BELGRADE, Mont., March 03, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, before the open of the financial markets on Tuesday, March 7, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Tuesday, March 7 at 9:00 AM ET to review results. Conference Details:Conference Date: Tuesday, March 7, 2023 – 9:00 AM ETConference dial-in: 877-407-6184International dial-in: 201-389-0877Conference Call Name: Xtant Medical Q4 2022 Financial ResultsWebcast Registration: Click Here Following the live call, a replay...

Continue reading

Invesco ltd: Form 8.3 – Shaftesbury PLC

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Shaftesbury plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

Societal CDMO to Participate at 35th Annual Roth Conference

SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate at the 35th Annual Roth Conference. Details of the company’s participation are as follows:35th Annual Roth ConferenceDetails: Societal management will participate in 1-on-1 meetingsConference Dates: March 12-14, 2023Location: The Ritz Carlton, Laguna Niguel in Dana Point, CaliforniaAbout Societal CDMOSocietal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development...

Continue reading

Orchard Therapeutics to Present at Multiple Investor Conferences in March 2023

BOSTON and LONDON, March 03, 2023 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that members of the management team will present at the following investor conferences:TD Cowen 43rd Annual Healthcare Conference on March 7, 2023, at 10:30 a.m. ET as part of a panel discussion focused on orphan neurology drug discovery and development (Boston) Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at 2:00 p.m. ET (virtual)Live webcasts of the presentations will be available under “News & Events” in the Investors & Media section of the company’s website at www.orchard-tx.com. Webcast replays will be archived on the Orchard website following the events. About Orchard At Orchard Therapeutics, our vision is to end the devastation caused by...

Continue reading

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance

Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 million, representing 40% growth Provides full year 2023 commercial revenue guidance of at least $22.0 million, representing growth of approximately 30% LOWELL, Mass., March 03, 2023 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2022. Recent HighlightsFourth quarter commercial revenue (combined product and service) of $4.4 million Fourth...

Continue reading

Wallbridge Files NI 43-101 Technical Report for Detour-Fenelon Gold Trend Property

TORONTO, March 03, 2023 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM, OTCQX:WLBMF) (“Wallbridge” or the “Company”) today announced the filing of a National Instrument 43-101 (“NI 43-101”) technical report (the “Technical Report”) in support of the updated mineral resource estimates for the Fenelon and Martiniere deposits (combined, the “Detour-Fenelon Gold Trend Property”) located on Wallbridge’s 830 km2 exploration land package on the Detour-Fenelon Gold Trend in Northern Abitibi, Quebec. The Technical Report was prepared in accordance with Canadian Securities Administrators’ NI 43-101 Standards of Disclosure for Mineral Projects and Form 43-101F1 and is available for review on SEDAR (sedar.com) and the Company’s website (wallbridgemining.com). About Wallbridge Mining Wallbridge is focused on creating value...

Continue reading

Interpublic Group to Present at the 2023 Morgan Stanley Technology, Media & Telecom Conference

New York, NY, March 03, 2023 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the 2023 Morgan Stanley Technology, Media & Telecom Conference on Wednesday, March 8th, 2023, at 6:20 pm Eastern Time/3:20 pm Pacific Time, as scheduled. A link to the live webcast will be posted on the day of the conference on the Investor Relations section of Interpublic’s website (http://investors.interpublic.com) where it will remain available for replay for 30 days. # # # About InterpublicInterpublic (NYSE: IPG) (www.interpublic.com) is a values-based, data-fueled, and creatively-driven provider of marketing solutions. Home to some of the world’s best-known and most innovative communications specialists, IPG global brands include Acxiom, Craft, FCB, FutureBrand, Golin, Huge, Initiative, IPG Health, Jack...

Continue reading

MacDonald Mines Confirms Several Positive Gravity Anomalies Characteristic of an Iron-Oxide-Copper-Gold Mineralization System

Prepares to Drill TargetsFigure 1. Gravity survey results from ALS GoldSpot’s inversion.Figure 2. Polymetallic mineralization along the McLaren Lake Fault Zone and location of Alwyn gravity survey.TORONTO, March 03, 2023 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK, OTC: MCDMF) (“MacDonald Mines” or the “Company”) is pleased to share the highlights from a broad gravity survey completed over the Alwyn Copper-Gold (“Cu-Au”) Trend (“Alwyn”) on it’s 100% owned SPJ Property (“SPJ”) near Sudbury, Ontario. Survey Highlights:ALS GoldSpot Discoveries Ltd. (“ALS GoldSpot”) has identified 5 high priority gravity targets potentially representing zones of iron-rich alteration associated along the prospective McLaren Lake Fault Zone (“MLFZ”) (see Figure 1) by integrating MacDonald Mines’ newly completed Alwyn gravity...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.